Single Molecule Force Spectroscopy Reveals Distinctions in Key Biophysical Parameters of αβ T-Cell Receptors Compared with Chimeric Antigen Receptors Directed at the Same Ligand.


Journal

The journal of physical chemistry letters
ISSN: 1948-7185
Titre abrégé: J Phys Chem Lett
Pays: United States
ID NLM: 101526034

Informations de publication

Date de publication:
12 Aug 2021
Historique:
pubmed: 5 8 2021
medline: 31 8 2021
entrez: 4 8 2021
Statut: ppublish

Résumé

Chimeric antigen receptor (CAR) T-cell therapies exploit facile antibody-mediated targeting to elicit useful immune responses in patients. This work directly compares binding profiles of CAR and αβ T-cell receptors (TCR) with single cell and single molecule optical trap measurements against a shared ligand. DNA-tethered measurements of peptide-major histocompatibility complex (pMHC) ligand interaction in both CAR and TCR exhibit catch bonds with specific peptide agonist peaking at 25 and 14 pN, respectively. While a conformational transition is regularly seen in TCR-pMHC systems, that of CAR-pMHC systems is dissimilar, being infrequent, of lower magnitude, and irreversible. Slip bonds are observed with CD19-specific CAR T-cells and with a monoclonal antibody mapping to the MHC α2 helix but indifferent to the bound peptide. Collectively, these findings suggest that the CAR-pMHC interface underpins the CAR catch bond response to pMHC ligands in contradistinction to slip bonds for CARs targeting canonical ligands.

Identifiants

pubmed: 34347491
doi: 10.1021/acs.jpclett.1c02240
pmc: PMC9082930
mid: NIHMS1800886
doi:

Substances chimiques

Ligands 0
Receptors, Antigen, T-Cell 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7566-7573

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI143565
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI136301
Pays : United States

Références

Nat Methods. 2004 Nov;1(2):133-9
pubmed: 15782176
Proc Natl Acad Sci U S A. 2021 Jun 29;118(26):
pubmed: 34172580
J Immunol. 2010 Jun 1;184(11):5959-63
pubmed: 20435924
Annu Rev Immunol. 2003;21:659-84
pubmed: 12615890
Front Phys. 2019 Feb;7:
pubmed: 31328129
Front Immunol. 2012 Apr 18;3:76
pubmed: 22566957
J Biol Chem. 2008 Oct 24;283(43):29053-9
pubmed: 18703505
Nat Rev Drug Discov. 2018 Mar;17(3):161-162
pubmed: 29375140
J Mol Biol. 2016 Jan 16;428(1):194-205
pubmed: 26688548
Gene Ther. 2014 Jun;21(6):575-84
pubmed: 24694533
Cell. 2014 Apr 10;157(2):357-368
pubmed: 24725404
Acc Chem Res. 2020 Oct 20;53(10):2044-2054
pubmed: 32877161
Sci Adv. 2020 May 20;6(21):eaaz3223
pubmed: 32637585
Trends Mol Med. 2017 May;23(5):430-450
pubmed: 28416139
J Am Chem Soc. 2020 Nov 4;142(44):18874-18885
pubmed: 32966054
PLoS One. 2011 May 10;6(5):e19680
pubmed: 21572959
J Biol Chem. 2016 Dec 2;291(49):25292-25305
pubmed: 27707880
J Am Chem Soc. 2015 Mar 4;137(8):2832-5
pubmed: 25692571
Immunity. 2018 Nov 20;49(5):829-841.e6
pubmed: 30389415
Adv Sci (Weinh). 2020 Nov 03;7(24):2002628
pubmed: 33344135
Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):E2068-E2076
pubmed: 29440406
J Phys Chem A. 2011 Apr 28;115(16):3657-64
pubmed: 20795685
Science. 2018 Mar 23;359(6382):1361-1365
pubmed: 29567707
J Biol Chem. 2009 Nov 6;284(45):31028-37
pubmed: 19755427
Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):E8204-E8213
pubmed: 28811364
Mol Biol Cell. 2015 Feb 15;26(4):685-95
pubmed: 25518938
Proc Natl Acad Sci U S A. 2020 Sep 1;117(35):21336-21345
pubmed: 32796106
Biophys J. 2017 Jul 11;113(1):120-131
pubmed: 28700910
Cancers (Basel). 2021 Feb 18;13(4):
pubmed: 33670734
Blood. 2016 Sep 8;128(10):1396-407
pubmed: 27338099
Trends Immunol. 2018 Aug;39(8):596-609
pubmed: 30060805
J Biol Chem. 1990 Jun 5;265(16):9296-301
pubmed: 2140571
Nat Chem Biol. 2018 Mar;14(3):317-324
pubmed: 29377003
Nat Rev Immunol. 2019 Feb;19(2):73-74
pubmed: 30631206
Acc Chem Res. 2019 Jun 18;52(6):1543-1554
pubmed: 31120725
Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):1517-22
pubmed: 25605925
Sci Rep. 2013 Nov 18;3:3232
pubmed: 24240815
Cell Mol Immunol. 2020 Jun;17(6):600-612
pubmed: 32451454
Biophys J. 2006 Aug 1;91(3):1069-77
pubmed: 16648165
Mol Cell. 2019 Mar 7;73(5):1015-1027.e7
pubmed: 30711376
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):9972-7
pubmed: 10963664
Tissue Antigens. 2013 Apr;81(4):212-20
pubmed: 23510417
Sci Rep. 2017 Aug 30;7(1):9923
pubmed: 28855662

Auteurs

Debasis Banik (D)

Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States.

Maryam Hamidinia (M)

Translational Immunology Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Translational Cancer Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.

Joanna Brzostek (J)

Translational Immunology Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Translational Cancer Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.

Ling Wu (L)

Translational Immunology Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Translational Cancer Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.

Hannah M Stephens (HM)

Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States.

Paul A MacAry (PA)

Translational Immunology Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Translational Cancer Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.

Ellis L Reinherz (EL)

Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, United States.
Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, United States.

Nicholas R J Gascoigne (NRJ)

Translational Immunology Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Translational Cancer Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.

Matthew J Lang (MJ)

Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States.
Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37235, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH